magnolol has been researched along with Osteosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JH; Hsu, FT; Hsu, LC; Ku, MC; Lee, KC; Lee, YH; Li, CH; Lin, RF; Wang, WC; Yang, CC; Yueh, PF | 1 |
1 other study(ies) available for magnolol and Osteosarcoma
| Article | Year |
|---|---|
Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma.
Topics: Apoptosis; Biphenyl Compounds; Bone Neoplasms; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; NF-kappa B; Osteosarcoma; Signal Transduction | 2022 |